89bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Selling, General & Admin	39.62	28.97	21.45	19.41	13.16	Upgrade
Research & Development	345.04	122.23	80.8	70.33	36.2	Upgrade
Operating Expenses	384.66	151.2	102.25	89.74	49.36	Upgrade
Operating Income	-384.66	-151.2	-102.25	-89.74	-49.36	Upgrade
Interest Expense	-5.29	-4.79	-1.92	-0.67	-	Upgrade
Interest & Investment Income	13.59	11.43	1.18	1.01	-	Upgrade
Other Non Operating Income (Expenses)	-	-	-	-	0.07	Upgrade
EBT Excluding Unusual Items	-376.36	-144.56	-102.99	-89.4	-49.29	Upgrade
Gain (Loss) on Sale of Investments	9.97	6.24	0.98	-0.87	-0.27	Upgrade
Pretax Income	-366.39	-138.32	-102.01	-90.27	-49.56	Upgrade
Income Tax Expense	0.69	3.87	0.02	-0.15	-0.06	Upgrade
Net Income	-367.08	-142.19	-102.03	-90.12	-49.5	Upgrade
Net Income to Common	-367.08	-142.19	-102.03	-90.12	-49.5	Upgrade
Shares Outstanding (Basic)	105	71	35	20	16	Upgrade
Shares Outstanding (Diluted)	105	71	35	20	16	Upgrade
Shares Change (YoY)	47.13%	104.48%	73.18%	24.93%	586.28%	Upgrade
EPS (Basic)	-3.51	-2.00	-2.93	-4.48	-3.08	Upgrade
EPS (Diluted)	-3.51	-2.00	-2.93	-4.48	-3.08	Upgrade
Free Cash Flow	-367.84	-129.19	-81.1	-76.84	-46.37	Upgrade
Free Cash Flow Per Share	-3.51	-1.81	-2.33	-3.82	-2.88	Upgrade
EBITDA	-384.62	-151.15	-102.18	-89.66	-49.3	Upgrade
D&A For EBITDA	0.04	0.05	0.07	0.08	0.06	Upgrade
EBIT	-384.66	-151.2	-102.25	-89.74	-49.36	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q